WashU

The Record

Friday, July 24, 2026

Top stories

WashU announces new Bristol Myers Squibb collaboration

WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will get to work alongside the company’s scientists.


New approach to designing drugs supercharges cancer medication

WashU Medicine researchers have shown in mice that a technique in which components of anti-cancer drugs are administered separately and assembled in the body is more effective at targeting and shrinking tumors.


Silkworm cultivation predated the Silk Road in southern Central Asia

The silkworm moth, whose caterpillars are used in silk production, may have been brought to southern Central Asia 4,000 years ago — nearly 2,000 years earlier than previously assumed — according to new research from Arts & Sciences.


Read more stories on the Source →

#MeetMeInSt.Louie: the Brickline Greenway

WashU in the News

The $2 billion question behind Kalshi’s new prediction market


Inc.


New York bill could create nation’s first system for tracking AI-related job layoffs


the national law review


Growing tomatoes without photosynthesis


Offrange


WashU wins first-ever Division III Directors’ Cup


Fox 2 St. Louis


See more WashU in the News →

Campus and community news

Research Wire

Studying mice, WashU Medicine researchers have identified communication signals linking skeletal muscle, the brain and brown fat tissue that play an important role in aging. The work could help promote healthier aging.


Notables

Three members of the WashU community — Tracey Hermanstyne-Jordan (left), Amanda Pope and Will Werner — have been selected for Focus St. Louis’ 2026-27 cohort of Leadership St. Louis. 


Notables

Kelley Van Dyck Murphy, Constance Vale and Chandler Ahrens — all architecture faculty at the WashU Sam Fox School — have won a Most Enhanced Award from the Landmarks Association of St. Louis for their work on The Key.


Perspectives

Why the headlines on Ozempic’s potential are easy to misread

Epidemiologist Ziyad Al-Aly, MD, at WashU Medicine, writes an article cutting through the hype about the potential of diabetes and weight-loss drugs such as Ozempic to prevent cancer.


the conversation


Read more Perspectives →